Clinical Trial Update: Sintilimab Plus Bevacizumab and Chemotherapy in MSS/pMMR Colorectal With no Liver Metastasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sintilimab plus bevacizumab and chemotherapy in MSS/pMMR colorectal cancer with no liver metastasis; the study status is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Chemotherapy (chemotherapy)
• Sintilimab (sintilimab)

Snippet

Sponsor: Anhui Provincial Cancer Hospital | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: NOT_YET_RECRUITING